Papers by Wen Chen

28 results

  1. Drug Design, Development and Therapy

    GLP-1 agonists linked to lower dementia risk after COVID-19

    GLP-1 receptor agonist initiation was associated with a lower hazard of incident dementia than DPP-4 inhibitors (HR 0.64) in diabetic COVID-19 survivors.GLP-1 receptor agonist initiation was associated with a lower hazard of incident dementia than DPP-4 inhibitors (HR 0.64) in diabetic COVID-19 survivors.

    Cohort study of 25,263 peopleGLP-1 receptor agonists
  2. Frontiers in Aging Neuroscience

    COVID-19 tied to higher dementia risk in older adults with diabetes

    Older adults had an overall dementia hazard ratio of 1.51 after documented infection compared with matched uninfected peers across up to six years of follow-up.Older adults had an overall dementia hazard ratio of 1.51 after documented infection compared with matched uninfected peers across up to six years of follow-up.

    Cohort study of 449,745 peopleVascular dementia